The sales appear to be part of a pre-arranged 10b5-1 plan or tax-driven exercise of vested options rather than a signal of fundamental concern. Traders should monitor for any changes in forward guidance or corporate strategy, but this cluster is consistent with routine insider activity for a company of this size.
Price Chart
Executive Summary
United Therapeutics CEO Martine Rothblatt and other insiders engaged in a series of derivative exercises and open-market sales over the past week, generating $2.8 million in total proceeds from stock sales. The activity is primarily tied to option exercises and tax-related sales, with the CEO accounting for the majority of transactions.
Key Financial Metrics
Key Facts
- CEO Martine Rothblatt exercised options for 95,000 shares across multiple days (10 tranches of 9,500 shares), with 5 tranches at $146.03 (total value $6.94M) and 5 at $0 (non-cash).
- Rothblatt sold 852 shares in open-market transactions totaling $447,085.17 at prices between $520.34 and $531.21.
- EVP Paul Mahon exercised options for 16,600 shares at $146.03 (value $2.42M) and sold 753 shares for $397,183.86.
- Director Jan Malcolm sold 45 shares for $24,007.95.
- Total open-market sales in the cluster: $868,277.01 across 1,649 shares.
- All derivative exercises were at a strike price of $146.03 or $0, suggesting expiration or vesting of long-held options.
Financial Impact
$868,277 in open-market sales and $9.36M in derivative exercises (mostly non-cash or tax-related)
Risk Factors
- Perception of insider selling could weigh on sentiment despite being routine.
- Future large-scale option exercises could lead to sustained selling pressure if used for liquidity.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (16 trades, 7d window) | cluster-UTHR-1774297898268 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $500.35 $497.31 | ▼ −0.61% | ▼ −2.72% | $552.73 (+10.47%) |
Sep 11, 2026 21d ago | Insider Cluster | $497.11 $494.63 | ▼ −0.50% | ▼ −0.28% | $552.73 (+11.19%) |
Sep 10, 2026 22d ago | Insider Cluster | $503.86 $497.27 | ▼ −1.31% | ▼ −0.81% | $552.73 (+9.70%) |
Sep 9, 2026 23d ago | Insider Cluster | $506.82 $498.48 | ▼ −1.65% | ▼ −0.99% | $552.73 (+9.06%) |
Sep 4, 2026 28d ago | Insider Cluster | $487.61 $502.70 | ▲ +3.09% | ▲ +4.30% | $552.73 (+13.36%) |
Sep 3, 2026 29d ago | Insider Cluster | $488.16 $497.11 | ▲ +1.83% | ▲ +2.98% | $552.73 (+13.23%) |
Aug 28, 2026 5w ago | Insider Cluster | $515.46 $487.61 | ▼ −5.40% | ▼ −5.51% | $552.73 (+7.23%) |
Aug 27, 2026 5w ago | Insider Cluster | $527.91 $492.02 | ▼ −6.80% | ▼ −6.03% | $552.73 (+4.70%) |
Aug 26, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $552.73 (+6.98%) |
Aug 25, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $552.73 (+6.98%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access